newsfilter
← Latest News
GlobeNewswire·

Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update

  • Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) will host a conference call at 5:00 p.m. ET on Tuesday, May 5, 2026.
  • The call will discuss financial results & a corporate update for the quarter ending March 31, 2026.
  • A live webcast & replay will be available via the company's investor relations website.
  • The call replay will remain accessible for three months following the event.
  • Ultragenyx focuses on developing & commercializing novel therapies for serious rare & ultra-rare genetic diseases.
  • The company maintains a diverse portfolio of approved treatments & product candidates targeting high unmet medical needs.
  • Investor inquiries should be directed to Joshua Higa at ir@ultragenyx.com.
  • Media inquiries should be directed to Jess Rowlands at media@ultragenyx.com.